Literature DB >> 32685043

Changing pattern of pheochromocytoma and paraganglioma in a stable UK population.

I T Cvasciuc1, S Gull1, R Oprean2, K H Lim3, F Eatock1.   

Abstract

CONTEXT: Pheochromocytomas and paragangliomas (PCC/PGLs) are diagnosed variously with increasing incidence and changing clinical and pathology pattern.
OBJECTIVE: The aim was to further characterize PCC/PGLs in a stable population.
METHODS: A retrospective, single institution study analysed adrenalectomies for PCC/PGLs between January 2010 - January 2019. Demographics, symptoms, blood pressure, preoperative hormones, imaging, histology, hospital stay, complications and three subgroups [based on the modality of diagnosis - incidentaloma group (IG), genetic group (GG) and symptomatic group (SG)] were noted.
RESULTS: 86 patients included IG 51 (59.3%), GG 10 (11.62%) and SG 25 patients (29.06%). Incidence was 5.30 cases/1 million population. 33.34% of the IG had a delayed diagnosis with a mean interval of 22.95 months (4-120 months). Females presented more often with paroxysmal symptoms (PS) (p=0.011). Patients with PS and classic symptoms were younger (p=0.0087, p=0.0004) and those with PS required more inotropes postoperatively (p=0.014). SG had higher preoperative hormone levels (p=0.0048), larger tumors (p=0.0169) and more likely females. GG are younger compared with those from the IG (p=0.0001) or SG (p= 0.178).
CONCLUSION: Majority of patients had an incidental and delayed diagnosis. If symptomatic, patients are more likely to be young females with higher hormone levels and larger tumors. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  PCC; PGL; clinical pattern; incidence; paraganglioma; pheochromocytoma

Year:  2020        PMID: 32685043      PMCID: PMC7363998          DOI: 10.4183/aeb.2020.78

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  29 in total

Review 1.  Diagnosis and management of pheochromocytoma.

Authors:  Richard Hodin; Carrie Lubitz; Roy Phitayakorn; Antonia Stephen
Journal:  Curr Probl Surg       Date:  2014-01-23       Impact factor: 1.909

Review 2.  Pheochromocytoma and abdominal paraganglioma.

Authors:  J Renard; T Clerici; M Licker; F Triponez
Journal:  J Visc Surg       Date:  2011-09-08       Impact factor: 2.043

3.  Germ-line mutations in nonsyndromic pheochromocytoma.

Authors:  Hartmut P H Neumann; Birke Bausch; Sarah R McWhinney; Bernhard U Bender; Oliver Gimm; Gerlind Franke; Joerg Schipper; Joachim Klisch; Carsten Altehoefer; Klaus Zerres; Andrzej Januszewicz; Charis Eng; Wendy M Smith; Robin Munk; Tanja Manz; Sven Glaesker; Thomas W Apel; Markus Treier; Martin Reineke; Martin K Walz; Cuong Hoang-Vu; Michael Brauckhoff; Andreas Klein-Franke; Peter Klose; Heinrich Schmidt; Margarete Maier-Woelfle; Mariola Peçzkowska; Cesary Szmigielski; Charis Eng
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

4.  Paraganglioma: not just an extra-adrenal pheochromocytoma.

Authors:  Amanda M Laird; Paul G Gauger; Gerard M Doherty; Barbra S Miller
Journal:  Langenbecks Arch Surg       Date:  2011-11-17       Impact factor: 3.445

5.  Phaeochromocytomas and functional paragangliomas: clinical management.

Authors:  Pierre-François Plouin; Laurence Amar; Charlotte Lepoutre
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-12       Impact factor: 4.690

Review 6.  Pheochromocytoma.

Authors:  E L Bravo; R W Gifford
Journal:  Endocrinol Metab Clin North Am       Date:  1993-06       Impact factor: 4.741

7.  Phaeochromocytoma in Queensland--1970-83.

Authors:  L Hartley; D Perry-Keene
Journal:  Aust N Z J Surg       Date:  1985-10

8.  Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?

Authors:  Roeland F Stolk; Carel Bakx; Jan Mulder; Henri J L M Timmers; Jacques W M Lenders
Journal:  J Clin Endocrinol Metab       Date:  2013-02-13       Impact factor: 5.958

9.  Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

Authors:  Malgorzata Oczko-Wojciechowska; Michal Swierniak; Jolanta Krajewska; Malgorzata Kowalska; Monika Kowal; Tomasz Stokowy; Bartosz Wojtas; Dagmara Rusinek; Agnieszka Pawlaczek; Agnieszka Czarniecka; Sylwia Szpak-Ulczok; Tomasz Gawlik; Ewa Chmielik; Tomasz Tyszkiewicz; Barbara Nikiel; Dariusz Lange; Michal Jarzab; Malgorzata Wiench; Barbara Jarzab
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

10.  Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center.

Authors:  Henrik Falhammar; Magnus Kjellman; Jan Calissendorff
Journal:  Endocr Connect       Date:  2017-12-07       Impact factor: 3.335

View more
  3 in total

1.  Actualities in the anaesthetic management of pheochromocytoma/ paraganglioma.

Authors:  D Godoroja-Diarto; C Moldovan; V Tomulescu
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

2.  THE ROLE OF TUMOR-SEEKING RADIOPHARMACEUTICALS IN THE DIAGNOSIS AND MANAGEMENT OF ADRENAL TUMORS.

Authors:  V Vukomanovic; M Matovic; A Djukic; V Ignjatovic; K Vuleta; S Djukic; I Simic Vukomanovic
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

3.  Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years.

Authors:  Abdul Rahman Al Subhi; Veronica Boyle; Marianne S Elston
Journal:  J Endocr Soc       Date:  2022-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.